Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant. | Front Immunol | 2021 | 34456920 | PubTator, text mining | PubMed |
| Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma. | Immun Inflamm Dis | 2021 | 34449972 | PubTator, text mining | PubMed |
| EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration. | Cancers (Basel) | 2021 | 34439264 | PubTator, text mining | PubMed |
| Juvenile Idiopathic Arthritis Associated Uveitis. | Children (Basel) | 2021 | 34438537 | PubTator, text mining | PubMed |
| Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma. | J Immunol Res | 2021 | 34426790 | PubTator, text mining | PubMed |
| ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 34426560 | PubTator, text mining | PubMed |
| The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells. | Cancer Immunol Res | 2021 | 34426457 | PubTator, text mining | PubMed |
| The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer. | Front Cell Dev Biol | 2021 | 34422829 | PubTator, text mining | PubMed |
| Optimizing T Cell-Based Therapy for Glioblastoma. | Front Immunol | 2021 | 34421912 | PubTator, text mining | PubMed |
| Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients. | Front Cell Dev Biol | 2021 | 34414187 | PubTator, text mining | PubMed |
| HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma. | Biologics | 2021 | 34413629 | PubTator, text mining | PubMed |
| Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. | Front Cell Dev Biol | 2021 | 34409029 | PubTator, text mining | PubMed |
| Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population. | Medicine (Baltimore) | 2021 | 34397730 | PubTator, text mining | PubMed |
| Pathology Quality Control for Multiplex Immunofluorescence and Image Analysis Assessment in Longitudinal Studies. | Front Mol Biosci | 2021 | 34395517 | PubTator, text mining | PubMed |
| Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer. | Front Immunol | 2021 | 34394098 | PubTator, text mining | PubMed |
| Glioblastoma Multiforme-A Look at the Past and a Glance at the Future. | Pharmaceutics | 2021 | 34371744 | PubTator, text mining | PubMed |
| Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis. | Front Oncol | 2021 | 34367975 | PubTator, text mining | PubMed |
| Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. | Cancers (Basel) | 2021 | 34359773 | PubTator, text mining | PubMed |
| Overcoming physical stromal barriers to cancer immunotherapy. | Drug Deliv Transl Res | 2021 | 34351575 | PubTator, text mining | PubMed |
| Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis. | Front Immunol | 2021 | 34335595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=57